20 Participants NeededMy employer runs this trial

Exercise with Blood Flow Restriction for Type 2 Diabetes

JP
Overseen ByJonathan P Little, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

To conduct a randomized control trial to determine the impact of acute blood flow restriction treadmill walking on immune cell counts, function, and phenotype in adults living with type 2 diabetes.

Are You a Good Fit for This Trial?

This trial is for adults with type 2 diabetes. Participants should be able to walk on a treadmill and not have any conditions that would make exercise unsafe, such as severe heart or lung problems.

Inclusion Criteria

Completing less than 150 minutes of moderate-vigorous physical activity per week
I am between 19 and 64 years old.
I have type 2 diabetes and my HbA1c is between 5.7% and 9.0%.

Exclusion Criteria

I have a chronic muscle or bone problem, or a recent heart issue that stops me from exercising.
I do not have blood vessel problems that prevent BFR therapy.
My type 2 diabetes medication has changed in the last 3 months.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Exercise with Blood Flow Restriction (BFR)

Trial Overview

The study compares two types of treadmill walking: one with blood flow restriction (using cuffs to limit blood flow in the legs) and one without. The goal is to see how these exercises affect immune cells in people with type 2 diabetes.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Treadmill walking with blood flow restrictionExperimental Treatment1 Intervention
Group II: Treadmill WalkingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+